Affiliation:
1. 1Department of Medicine and
2. 2Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA; and
3. 3Abramson Cancer Center and
4. 4Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA
Abstract
Abstract
Objective: To investigate differences in attitudes about predictive genetic testing for cancer risk between African-American and Caucasian residents of the city of Philadelphia. Methods: Cross-sectional survey of awareness of and attitudes about predictive genetic testing, using an instrument developed through focus groups with the general public, literature review, and expert opinion. Setting: Municipal County Courthouse of Philadelphia. Respondents: Male and female adults waiting to be assigned to jury duty. Results: Of the 430 respondents, 43% (170) were African-American and 45% (181) Caucasian. Awareness of predictive genetic testing was higher among Caucasians (72%) than African-Americans (49%). After adjustment for age, gender, and educational attainment, African-Americans were more likely to report that the government would use genetic tests to label groups as inferior, and less likely to endorse the potential health benefits of testing, including “help my doctor manage my health care,” “help me change my lifestyle,” and “help scientists find cures for diseases.” These associations remained if the sample was restricted to participants who had heard of genetic testing before the survey. Conclusions: In the city of Philadelphia, awareness of and attitudes about predictive genetic testing for cancer risk differ by race, with lower awareness, less belief in the potential benefits of testing, and more concern about racial discrimination from genetic testing among African-Americans than Caucasians. These differences may result in disparities in the uptake of predictive genetic testing in the future.
Publisher
American Association for Cancer Research (AACR)
Reference38 articles.
1. Condit C. What is public opinion about genetics. Nat Genet, 2001;2:811–5.
2. Armstrong K, Calzone K, Stopfer J, Fitzgerald G, Coyne J, Weber B. Factors associated with decisions about clinical BRCA1/2 testing. Cancer Epidemiol Biomarkers & Prev, 2000;9:1251–4.
3. Lerman C, Daly M, Masny A, Balshem A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol, 1994;12:843–50.
4. Bluman L, Rimer B, Berry D, et al. Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2. J Clin Oncol, 1999;17:1040–6.
5. Armstrong K, Ubel P, Weber B, Guerra C, Schwartz JS. Interest in BRCA1/2 testing in a primary care population. Prev Med, 2002;34:590–5.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献